The annual Tom Main Health Innovation Mentorship pairs health industry entrepreneurs with senior members of the Oliver Wyman Health and Life Sciences practice. This year’s winner was Corbin Petro, CEO and Co-founder of Eleanor Health, an evidenced-based, whole person care provider that addresses the unique complexities of individuals and populations with substance use disorder and mental health needs. Corbin and her Oliver Wyman mentors addressed Eleanor Health’s greatest business challenges to ultimately guide the organization toward near- and long-term success. The Tom Main Health Innovation Mentorship was created in honor of our former colleague and Oliver Wyman Health Innovation Center (OWHIC) founder, the late Tom Main.
Petro is the second mentee to go through the program. She follows Lisa Alderson, CEO and Founder of Genome Medical, Inc., a genomics medical practice delivering genetic expertise to patients, providers, and employers across the US.
Oliver Wyman supported Eleanor Health to develop and sharpen its overall commercialization approach, with a particular focus on customer segmentation, value proposition development, and value-based pricing strategy. The mentors leveraged their collective experience, industry knowledge, and the power of the broader Oliver Wyman and Marsh McLennan family to accelerate Eleanor Health’s growth and impact.
The Mentorship provided opportunities to engage with business leaders from across industry sectors who I don’t normally get to connect with – to understand what is top of mind for them, and what is most important. The access to strategic experts and conversations with SMEs helped me think more broadly and differently about the challenges we were dealing with.Corbin Petro, CEO and Co-Founder of Eleanor Health and 2021 Tom Main Health Innovation Mentorship Mentee
For the last year, we’ve had the absolute privilege to get to know Corbin Petro and the team at Eleanor Health. In an incredibly short time, Eleanor has built a company and new platform to engage and support people dealing with substance use disorder (SUD). They’ve done this with an incredible focus on doing what is right and what has impact, while seeking to leave no one behind because of payer class. This is exactly the kind of transformative thinking into which Tom Main, a mentor of mine, would have thrust his energy and passion. We are excited not only to see Eleanor scale as a successful business, but also to see it deliver on its goal to help people dealing with SUD to live their best lives.Dan Shellenbarger, Partner, Health and Life Sciences, Oliver Wyman and 2021 Tom Main Health Innovation Mentor
As the spotlight on mental health grows, substance use disorder and addiction treatment is becoming an increasing focus as we think about whole person health management with our clients. Supporting Corbin and her team at Eleanor Health, who are using value-based models rooted in evidence-led protocols to drive better outcomes within this traditionally difficult to manage population, allowed us to be thoughtful, creative, and impact-focused.Hailey Fowler, Principal, Health and Life Sciences, Oliver Wyman and 2021 Tom Main Health Innovation Mentor
2021 Panel of Judges:
- Lisa Alderson (CEO and Founder of Genome Medical and 2020 Tom Main Health Innovation Mentee)
- Rohith Banerjee (Partner, Health and Life Sciences, Oliver Wyman)
- Jeanne Cohen (CEO, Motive Practicing Wisely Solutions)
- Sam Glick (Partner and Global Head, Health and Life Sciences, Oliver Wyman and 2020 Tom Main Health Innovation Mentor)
- Jeff Margolis (Chairman of the Board, Welltok)
- Tom Robinson (Partner and San Francisco Metro Lead, Health and Life Sciences, Oliver Wyman)
- Grace Terrell (Former CEO, Eventus WholeHealth)